Relypsa Inc


Brean Capital Bullish on Relypsa Inc (RLYP) on Solid Veltassa Prescription Numbers

Brean Capital analyst Difei Yang sees great promise for the future of Relypsa Inc (NASDAQ:RLYP), as the pharmaceutical giant just delivered June results …

Morgan Stanley Weighs In on Two Biotechs: Relypsa Inc (RLYP), Horizon Pharma PLC (HZNP)

Morgan Stanley analysts gave their opinions on the outlook of healthcare companies Relypsa Inc (NASDAQ:RLYP) and Horizon Pharma PLC (NASDAQ:HZNP). Below, one analyst discuss …

Tuesday Morning’s Market Insights: Relypsa Inc (RLYP), LendingClub Corp (LC), Regulus Therapeutics Inc (RGLS), Seadrill Ltd (SDRL)

Relypsa Inc (NASDAQ:RLYP) is up 6% after the company announced positive results from a pre-specified exploratory analysis of  a Phase 3 trial of …

Company Update (NASDAQ:RLYP): Relypsa Inc Announces Results of Pre-Specified Exploratory Analysis of Phase 3 OPAL-HK Study

Relypsa, Inc. (NASDAQ:RLYP), a biopharmaceutical company, today announced that results of a pre-specified exploratory analysis of the Phase 3 OPAL-HK trial of Veltassa® …

Biotech Beat: All Eyes On Relypsa Inc (RLYP) And EXACT Sciences Corporation (EXAS)

Both Relypsa Inc (NASDAQ:RLYP) and EXACT Sciences Corporation (NASDAQ:EXAS) received good news about their flagship products this week. Relypsa announced May prescription data …

Analysts Speculate On Three Biotech Stocks: Relypsa Inc (RLYP), Mast Therapeutics Inc (MSTX), SCYNEXIS Inc (SCYX)

Relypsa Inc Wedbush analyst Liana Moussatos reiterated an Outperform rating on shares of Relypsa Inc (NASDAQ:RLYP), with a $51 price target, after hosting an expert …

Stock Update (NASDAQ:RLYP): Relypsa Inc Announces New Employment Inducement Grants

Relypsa Inc (NASDAQ:RLYP), a biopharmaceutical company, announced that on June 1, 2016, the compensation committee of the company’s board of directors granted 2 …

Biotech Insights: Analysts Shine Light on Valeant Pharmaceuticals Intl Inc (VRX) and Relypsa Inc (RLYP)

Many biotech analysts have turned against drug makers Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Relypsa Inc (NASDAQ:RLYP) as the former faces several fraud allegations and …

Analysts Weigh In on Relypsa Inc (RLYP) and Sarepta Therapeutics Inc (SRPT) Following Updates about Competing Products

In biotech, knowing the competition is integral to understanding how drugs will succeed once they are on the market. Below, analysts weigh in …

Two Analysts Share Views On What’s In Store For Relypsa Inc (RLYP) And Intercept Pharmaceuticals Inc (ICPT)

Both Relypsa Inc (NASDAQ:RLYP) and Intercept Pharmaceuticals Inc (NASDAQ:ICPT) received welcome news recently as a competing drug to Relypsa’s Veltassa encounters some difficulties …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts